4640 Results

People

  1. Saltz
    Saltz
  2. O'Reilly
    O'Reilly
  3. Abou-Alfa
    Abou-Alfa
  4. Kelsen
    Kelsen
  5. Ilson
    Ilson
  6. Kemeny
    Kemeny
  7. Janjigian
    Janjigian
  8. Reidy
    Reidy
  9. Jarnagin
    Jarnagin
  10. D'Angelica
    D'Angelica

Groups

  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)
  7. Epidemiology and Biostatistics (828)
  8. GSK Faculty (793)
  9. Department of Pathology and Laboratory Medicine (723)
  10. Biostatistics Service (661)
  1. "Gastrointestinal Oncology Service"
Formats
  1. Journal Article (2302)
  2. Meeting Abstract (1841)
  3. Review (139)
  4. Book Section (123)
  5. Editorial (93)
  6. Guidelines (36)
  7. Correspondence (33)
  8. Conference Paper (23)
  9. Miscellaneous (21)
  10. Research Letter (17)
  11. Book Whole (12)
Groups
  1. Gastrointestinal Oncology Service (4640)
  2. Solid Tumor Oncology Division (4640)
  3. Department of Medicine (4638)
  4. Center for Pancreatic Cancer Research (2270)
  5. Surgery (1040)
  6. Survivorship Research (992)

More Groups

People
  1. Leonard Saltz (790)
  2. Eileen O'Reilly (780)
  3. Ghassan Abou-Alfa (568)
  4. Nancy Kemeny (543)
  5. David Kelsen (537)
  6. David Ilson (433)

More People

Years
  1. 2025 (118)
  2. 2024 (307)
  3. 2023 (362)
  4. 2022 (346)
  5. 2021 (345)
  6. 2020 (326)

More Years

Publications
  1. Journal of Clinical Oncology (1276)
  2. Annals of Oncology (320)
  3. Annals of Surgical Oncology (140)
  4. Cancer (127)
  5. Clinical Cancer Research (107)
  6. Cancer Research (94)

More Publications

Publishers
  1. American Society of Clinical Oncology (1355)
  2. Oxford University Press (447)
  3. Elsevier Inc. (404)
  4. Springer (310)
  5. American Association for Cancer Research (279)
  6. Wiley Blackwell (239)

More Publishers

Results (4640)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase I/II multisite study of nivolumab and carboplatin/paclitaxel with radiation therapy (RT) in patients with locally advanced esophageal squamous cell carcinoma (ESCC)
    Meeting Abstract

    Wu, J. J.; Atkinson, E. C.; Leichman, L. P.; Patel, H.; Iqbal, S.; Du, K. L.; Bizekis, C.; Goldberg, J. D.; Thomas, C. R.; Cohen, D. J.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • First-line durvalumab + monalizumab, mFOLFOX6, and bevacizumab or cetuximab for metastatic microsatellite-stable colorectal cancer (MSS-CRC)
    Meeting Abstract

    Wainberg, Z. A.; Diamond, J. R.; Curigliano, G.; Deva, S.; Bendell, J. C.; Han, S. W.; Kalyan, A.; Naidoo, J.; Kim, R. D.; Patel, S. P.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Pharmacogenomic blood-based assay to predict chemotherapy response and survival in pancreatic cancer
    Meeting Abstract

    Yu, K. H.; McCarthy, B.; Isacoff, W. H.; Cooper, B.; Bartlett, A.; Park, J.; Purcell, F.; McCarthy, D.; O'Reilly, E. M.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Young-onset pancreas cancer (PC) in patients less than or equal to 50 years old at Memorial Sloan Kettering (MSK): Descriptors, genomics, and outcomes
    Meeting Abstract

    Varghese, A. M.; Singh, I.; Singh, R. R.; Capanu, M.; Chou, J. F.; Wong, W.; Stadler, Z. K.; Salo-Mullen, E. E.; Iacobuzio-Donahue, C. A.; Kelsen, D. P.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Adverse events (AEs) with maintenance olaparib in patients with a germline BRCA mutation (gBRCAm) and metastatic pancreatic cancer (mPaC): Phase III POLO trial
    Meeting Abstract

    Reni, M.; Kindler, H. L.; Hammel, P.; Van Cutsem, E.; Macarulla, T.; Hall, M. J.; Park, J. O.; Hochhauser, D.; Arnold, D.; Oh, D. Y.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • How to improve toxicity evaluation in clinical trials? Testing new metrics from irinotecan or oxaliplatin-based treatments in metastatic colorectal cancer (mCRC): A pooled analysis from 2,349 patients in ARCAD database
    Meeting Abstract

    Tournigand, C.; Lopes, G.; Olswold, C. L.; Adams, R.; Zalcberg, J. R.; Van Cutsem, E.; Saltz, L. B.; Goldberg, R. M.; Hurwitz, H.; Bokemeyer, C.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase III, international, randomized trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P plus G) versus gemcitabine (G) for resected pancreatic cancer (APACT): Recurrence patterns
    Meeting Abstract

    Sahai, V.; Tabernero, J.; Van Cutsem, E.; Reni, M.; Tempero, M. A.; O'Reilly, E. M.; Berlin, J.; Riess, H.; Goldstein, D.; Li, M.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Phase Ib/II open-label, randomized evaluation of 2L atezolizumab (atezo) + BL-8040 versus control in MORPHEUS-pancreatic ductal adenocarcinoma (M-PDAC) and MORPHEUS-gastric cancer (M-GC)
    Meeting Abstract

    Oh, D. Y.; Ajani, J. A.; Bang, Y. J.; Chung, H. C.; Lacy, J.; Lee, J.; Macarulla, T.; Manji, G. A.; O'Reilly, E. M.; Allen, S.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Receipt and survival outcomes by age following second-line therapy for metastatic CRC (mCRC): Analysis of 5,289 patients from the ARCAD Clinical Trials Program
    Meeting Abstract

    McCleary, N. J.; Harmsen, W. S.; VanCutsem, E.; Sobrero, A. F.; Goldberg, R. M.; Tabernero, J.; Seymour, M.; Saltz, L. B.; Giantonio, B. J.; Dirk, A.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Impact of prior irinotecan exposure on outcomes of metastatic pancreatic cancer (mPC) patients
    Meeting Abstract

    O'Reilly, E. M.; Surinach, A.; Dillon, A.; Cockrum, P.; Yu, K. H.
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save